Related Experiment Video

Updated: Jul 17, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Anti-estrogen induced synthesis of transforming growth factor-beta in breast cancer patients

M R Mirza1

  • 1Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

Cancer Treatment Reviews
|June 1, 1991
PubMed

Insights

Anti-estrogens may influence aggressive estrogen receptor-negative breast cancer growth. These drugs stimulate Transforming Growth Factor-beta (TGF-beta), potentially inhibiting tumor cell proliferation via autocrine/paracrine pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Estrogen receptor-negative breast cancer is typically aggressive and hormone-independent.
  • Anti-estrogens have shown potential influence on the growth of these tumors.
  • Transforming Growth Factor-beta (TGF-beta) is implicated in cellular growth regulation.

Purpose of the Study:

  • To investigate the effect of anti-estrogens on estrogen receptor-negative breast cancer.
  • To explore the role of Transforming Growth Factor-beta (TGF-beta) in mediating anti-estrogen effects.
  • To understand the mechanism of cellular proliferation inhibition by TGF-beta in breast cancer.

Main Methods:

  • Analysis of anti-estrogen effects on hormone-dependent and independent breast cancer cell lines.
  • Measurement of Transforming Growth Factor-beta (TGF-beta) production in response to anti-estrogens.
  • Evaluation of TGF-beta's impact on cellular proliferation via autocrine/paracrine signaling.

Main Results:

  • Anti-estrogens demonstrated an influence on the growth of estrogen receptor-negative breast cancer models.
  • Stimulation of Transforming Growth Factor-beta (TGF-beta) production was observed in response to anti-estrogens.
  • TGF-beta mediated the inhibition of cellular proliferation in both hormone-dependent and independent cell lines.

Conclusions:

  • Anti-estrogens may represent a therapeutic strategy for estrogen receptor-negative breast cancer.
  • Transforming Growth Factor-beta (TGF-beta) plays a key role in mediating the anti-proliferative effects of anti-estrogens.
  • The autocrine/paracrine action of TGF-beta is a significant mechanism in controlling breast cancer cell growth.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...